Tumor‐microenvironment‐responsive nanomedicine for enhanced cancer immunotherapy
S Peng, F ** new nanomedicines during the past few years has
witnessed significant progress in diverse biomedical fields, especially for combating drug …
witnessed significant progress in diverse biomedical fields, especially for combating drug …
Phosphorous dendron micelles as a nanomedicine platform for cooperative tumor chemoimmunotherapy via synergistic modulation of immune cells
M Zhan, J Qiu, Y Fan, L Chen, Y Guo… - Advanced …, 2023 - Wiley Online Library
Abstract Design of effective nanomedicines to modulate multiple immune cells to overcome
the immune‐suppressive tumor microenvironment is desirable to improve the overall poor …
the immune‐suppressive tumor microenvironment is desirable to improve the overall poor …
Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment
Y Pan, L Liu, X Mou, Y Cai - ACS nano, 2023 - ACS Publications
Cancer with a complex pathological process is a major disease to human welfare. Due to
the imbalance between oxygen (O2) supply and consumption, hypoxia is a natural …
the imbalance between oxygen (O2) supply and consumption, hypoxia is a natural …
Immunogenic cell death inducers for enhanced cancer immunotherapy
Y Li, X Liu, X Zhang, W Pan, N Li, B Tang - Chemical Communications, 2021 - pubs.rsc.org
Inducing the immunogenic cell death (ICD) of cancer cells is an important method to improve
the immunogenicity of tumor cells for enhanced cancer immunotherapy. Therefore, we …
the immunogenicity of tumor cells for enhanced cancer immunotherapy. Therefore, we …
Plasmon‐driven catalytic chemotherapy augments cancer immunotherapy through induction of immunogenic cell death and blockage of IDO pathway
Y Ding, Z Sun, Y Gao, S Zhang, C Yang… - Advanced …, 2021 - Wiley Online Library
Clinical trials confirm the combination of indoleamine 2, 3‐dioxygenase (IDO) blockade and
immunogenic chemotherapy represents a brilliant future in cancer therapy. However, it …
immunogenic chemotherapy represents a brilliant future in cancer therapy. However, it …
Harnessing immune response using reactive oxygen Species-Generating/Eliminating inorganic biomaterials for disease treatment
With the increasing understanding of various biological functions mediated by reactive
oxygen species (ROS) in the immune system, a number of studies have been designed to …
oxygen species (ROS) in the immune system, a number of studies have been designed to …
Recent advances in stimulus‐responsive nanocarriers for gene therapy
C Yu, L Li, P Hu, Y Yang, W Wei, X Deng… - Advanced …, 2021 - Wiley Online Library
Gene therapy provides a promising strategy for curing monogenetic disorders and complex
diseases. However, there are challenges associated with the use of viral delivery vectors …
diseases. However, there are challenges associated with the use of viral delivery vectors …